These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 1771591)

  • 21. Quantifying Proximal Collecting Tubule Deficiency in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Fetopathy.
    Saunders J; Callejas Salgado AM; Ting JY; Mammen C; Terry J; Bush JW
    Pediatr Dev Pathol; 2021; 24(5):438-444. PubMed ID: 34082612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exposure to angiotensin-converting enzyme inhibitors during first trimester: is it safe to fetus?
    Yip SK; Leung TN; Fung HY
    Acta Obstet Gynecol Scand; 1998 May; 77(5):570-1. PubMed ID: 9654182
    [No Abstract]   [Full Text] [Related]  

  • 23. Gestational therapy with an angiotensin II receptor antagonist and transient renal failure in a premature infant.
    Bass JK; Faix RG
    Am J Perinatol; 2006 Jul; 23(5):313-7. PubMed ID: 16799914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin converting enzyme inhibitors in pregnancy.
    Mastrobattista JM
    Semin Perinatol; 1997 Apr; 21(2):124-34. PubMed ID: 9201818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Toxicity of levorin to pregnant rats and their fetus].
    Slonitskaia NN
    Antibiotiki; 1970 Dec; 15(12):1089-93. PubMed ID: 4322740
    [No Abstract]   [Full Text] [Related]  

  • 26. [Inhibition of the renin angiotensin system in pregnancy and risk of fetal malformations].
    Lonati C; Morganti A
    Pediatr Med Chir; 2009; 31(3):137-9. PubMed ID: 19739495
    [No Abstract]   [Full Text] [Related]  

  • 27. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity.
    Schaefer C
    Birth Defects Res A Clin Mol Teratol; 2003 Aug; 67(8):591-4. PubMed ID: 14632309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Captopril use in pregnancy and its effects on the fetus and the newborn: case report].
    Sadeck LS; Fernandes M; Silva SM; Trindade AA; Chia CY; Ramos JL; Leone CR
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(6):328-32. PubMed ID: 9629744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy.
    Hanssens M; Keirse MJ; Vankelecom F; Van Assche FA
    Obstet Gynecol; 1991 Jul; 78(1):128-35. PubMed ID: 2047053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Angiotensin-converting enzyme inhibitors. Principles and rules of use].
    Eicher JC; Wolf JE
    Rev Prat; 1998 Apr; 48(7):771-6. PubMed ID: 11767373
    [No Abstract]   [Full Text] [Related]  

  • 31. [The use of angiotensin converting enzyme (ACE) inhibitors during pregnancy clearly increases the risk of congenital malformations].
    de Leeuw PW
    Ned Tijdschr Geneeskd; 2006 Jul; 150(29):1605-7. PubMed ID: 16901062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors.
    Cooper WO
    J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme inhibitor fetopathy: long-term outcome.
    Laube GF; Kemper MJ; Schubiger G; Neuhaus TJ
    Arch Dis Child Fetal Neonatal Ed; 2007 Sep; 92(5):F402-3. PubMed ID: 17284475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis.
    Gribouval O; Gonzales M; Neuhaus T; Aziza J; Bieth E; Laurent N; Bouton JM; Feuillet F; Makni S; Ben Amar H; Laube G; Delezoide AL; Bouvier R; Dijoud F; Ollagnon-Roman E; Roume J; Joubert M; Antignac C; Gubler MC
    Nat Genet; 2005 Sep; 37(9):964-8. PubMed ID: 16116425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal exposure to lisinopril: neonatal manifestations and management.
    Bhatt-Mehta V; Deluga KS
    Pharmacotherapy; 1993; 13(5):515-8. PubMed ID: 8247923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Warfarin embryopathy.
    Warkany J
    Teratology; 1976 Oct; 14(2):205-9. PubMed ID: 790626
    [No Abstract]   [Full Text] [Related]  

  • 37. ACE inhibitors and birth defects.
    Prescrire Int; 2006 Dec; 15(86):223. PubMed ID: 17167930
    [No Abstract]   [Full Text] [Related]  

  • 38. Fetal renin-angiotensin-system blockade syndrome: renal lesions.
    Plazanet C; Arrondel C; Chavant F; Gubler MC
    Pediatr Nephrol; 2014 Jul; 29(7):1221-30. PubMed ID: 24477978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II receptor blocker induced fetopathy: 7 cases.
    Hünseler C; Paneitz A; Friedrich D; Lindner U; Oberthuer A; Körber F; Schmitt K; Welzing L; Müller A; Herkenrath P; Hoppe B; Gortner L; Roth B; Kattner E; Schaible T
    Klin Padiatr; 2011 Jan; 223(1):10-4. PubMed ID: 21271514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethylenethiourea: teratogenicity study in rats and rabbits.
    Khera KS
    Teratology; 1973 Jun; 7(3):243-52. PubMed ID: 4807127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.